ES469895A1 - Procedimiento para la obtencion de derivados de alquilendia-mina - Google Patents

Procedimiento para la obtencion de derivados de alquilendia-mina

Info

Publication number
ES469895A1
ES469895A1 ES469895A ES469895A ES469895A1 ES 469895 A1 ES469895 A1 ES 469895A1 ES 469895 A ES469895 A ES 469895A ES 469895 A ES469895 A ES 469895A ES 469895 A1 ES469895 A1 ES 469895A1
Authority
ES
Spain
Prior art keywords
sub
radical
dioxopyrimidyl
aryloxypropyl
alkylenediamines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES469895A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cassella Farbwerke Mainkur AG
Original Assignee
Cassella Farbwerke Mainkur AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cassella Farbwerke Mainkur AG filed Critical Cassella Farbwerke Mainkur AG
Publication of ES469895A1 publication Critical patent/ES469895A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES469895A 1977-05-16 1978-05-16 Procedimiento para la obtencion de derivados de alquilendia-mina Expired ES469895A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU77339A LU77339A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-05-16 1977-05-16

Publications (1)

Publication Number Publication Date
ES469895A1 true ES469895A1 (es) 1979-09-16

Family

ID=19728575

Family Applications (1)

Application Number Title Priority Date Filing Date
ES469895A Expired ES469895A1 (es) 1977-05-16 1978-05-16 Procedimiento para la obtencion de derivados de alquilendia-mina

Country Status (30)

Country Link
US (1) US4216314A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS53141285A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR224251A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (2) AT359523B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU3610578A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE867116A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG (2) BG28699A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1085842A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS (1) CS203005B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (1) DD135489A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2819629A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK203078A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EG (1) EG13302A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES469895A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI781461A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2391199A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1583428A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR71668B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE46895B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1158712B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU77339A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL7804966A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO781635L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ187272A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (2) PL113674B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT68044B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RO (1) RO75870A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE7805260L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SU (2) SU793389A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA782758B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3023369A1 (de) * 1980-06-23 1982-01-14 Boehringer Mannheim Gmbh, 6800 Mannheim Aryloxypropanolamine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3048487A1 (de) * 1980-12-22 1982-07-29 Cassella Ag, 6000 Frankfurt Basisch substituierte pyridazine, ihre herstellung und ihre verwendung
DE3131146A1 (de) * 1981-08-06 1983-02-24 Boehringer Mannheim Gmbh, 6800 Mannheim Neue heteroaryloxypropanolamine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JPS59225170A (ja) * 1983-06-07 1984-12-18 Mitsui Toatsu Chem Inc アミノプロパノ−ル誘導体、その製造法、および該化合物を含有する心臓選択性β−アドレナリン作用遮断剤
JPH0637479B2 (ja) * 1987-12-28 1994-05-18 三井東圧化学株式会社 新規ピリミジン誘導体、その製造法およびそれを含有する抗不整脈剤
US5008267A (en) * 1988-10-29 1991-04-16 Mitsui Toatsu Chemicals, Incorporated Pyrimidinedione compounds, method of producing the same and antiarrythmic agents containing the same
US5308848A (en) * 1989-10-24 1994-05-03 Mitsui Toatsu Chemicals, Incorporated Pyrimidinedione derivatives and antiarrythmic agents containing the same
JP2815218B2 (ja) * 1990-04-13 1998-10-27 三井化学株式会社 ピリミジンジオン誘導体、およびそれを含有する抗不整脈剤
JPH03173885A (ja) * 1989-12-01 1991-07-29 Mitsui Toatsu Chem Inc ピリミジンジオン誘導体化合物、該化合物の製造法および該化合物を含む抗不整脈剤
JPH0413669A (ja) * 1990-04-27 1992-01-17 Mitsui Toatsu Chem Inc 新規ピリミジンジオン誘導体及び該化合物を含有する抗不整脈剤
DE4035599A1 (de) * 1990-11-06 1992-05-07 Dresden Arzneimittel Neue 5-(phenoxyalkanoylamino)-uracile, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP1387673B1 (en) 2001-05-11 2010-12-29 Endo Pharmaceuticals Inc. Abuse-resistant controlled-release opioid dosage form
DK2425821T5 (en) 2002-04-05 2018-02-12 Mundipharma As Pharmaceutical preparation containing oxycodone and naloxone
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
AU2010223323B2 (en) 2009-03-10 2013-07-04 Euro-Celtique S.A. Immediate release pharmaceutical compositions comprising oxycodone and naloxone
US10071089B2 (en) 2013-07-23 2018-09-11 Euro-Celtique S.A. Combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE787103A (fr) * 1971-08-04 1973-02-02 Pfizer Nouveaux derives de propanolamine et composition pharmaceutiqueles contenant
US4020071A (en) * 1973-12-20 1977-04-26 Cassella Farbwerke Mainkur Aktiengesellschaft Derivatives of 1-phenoxy-3-amino-propan-2-ol

Also Published As

Publication number Publication date
IT1158712B (it) 1987-02-25
AR224251A1 (es) 1981-11-13
PL113762B1 (en) 1980-12-31
DE2819629A1 (de) 1978-11-30
SU841587A3 (ru) 1981-06-23
GB1583428A (en) 1981-01-28
PL206810A1 (pl) 1979-04-09
SU793389A3 (ru) 1980-12-30
FR2391199A1 (fr) 1978-12-15
NO781635L (no) 1978-11-17
LU77339A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1979-01-19
ZA782758B (en) 1979-05-30
SE7805260L (sv) 1978-11-17
BE867116A (fr) 1978-11-16
BG28700A3 (bg) 1980-06-16
EG13302A (en) 1983-09-30
IE780971L (en) 1978-11-16
IT7823416A0 (it) 1978-05-15
BG28699A3 (bg) 1980-06-16
CA1085842A (en) 1980-09-16
DK203078A (da) 1978-11-17
CS203005B2 (en) 1981-02-27
NL7804966A (nl) 1978-11-20
AU3610578A (en) 1979-11-22
ATA343078A (de) 1980-04-15
RO75870A (ro) 1982-12-06
IE46895B1 (en) 1983-10-19
FR2391199B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1981-07-24
JPS53141285A (en) 1978-12-08
ATA342978A (de) 1980-04-15
AT359523B (de) 1980-11-10
DD135489A5 (de) 1979-05-09
US4216314A (en) 1980-08-05
FI781461A7 (fi) 1978-11-17
PT68044A (de) 1978-06-01
AT359522B (de) 1980-11-10
PL113674B1 (en) 1980-12-31
GR71668B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1983-06-20
NZ187272A (en) 1979-12-11
PT68044B (de) 1979-10-24

Similar Documents

Publication Publication Date Title
ES469895A1 (es) Procedimiento para la obtencion de derivados de alquilendia-mina
ES478051A1 (es) Procedimiento para la preparacion de nuevos nitroimidazoles.
ES2033840T3 (es) P-aminoetilsulfonanilidas n-sustituidas como agentes antiarritmicos; e intermedios para los mismos.
ES478228A1 (es) Procedimiento para la preparacion de derivados de acidos fe-noxi-alcohilcarboxilicos.
ES478200A1 (es) Un procedimiento para la preparacion de ftalazinas.
ES474592A1 (es) Procedimiento para la preparacion de derivados de imidazoli-nina
ES2183950T3 (es) Aminas biciclicas como insecticidas.
AR219935A1 (es) (n- (3-tetrahidrofuranon-2) -n- (acetil)anilidas utiles como fungicidas, procedimiento para su obtencion y composiciones que las contienen
ES488657A1 (es) Procedimiento para la preparacion de derivados de aminopro- panol
ES473818A1 (es) Procedimiento para preparar derivados de piperazina.
ES475218A1 (es) Un procedimiento para la preparacimon de derivados de n'-(4-fenetiloxisustituido)-fenil)-n-metil-n-metoxiureas.
ES469265A1 (es) Procedimiento para la fabricacion de derivados del acido omega-aminoacilamisulfonico
ES2000705A6 (es) Procedimiento de preparacion de nuevas benzamidas y sus sales
FR2383185A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR2367743A1 (fr) Derives aryle conten
AR240814A2 (es) Nuevos derivados de acilamino-s-triazina, procedimiento para su preparacion y composiciones antiparasitarias que los contienen, excluida su actividad terapeutica.
ES457803A1 (es) Procedimiento para la preparacion de derivados de benzodio- xol.
ES470738A1 (es) Procedimiento para la obtencion de nuevos derivados de ni- trosourea
ES8301221A1 (es) Un procedimiento para la preparacion de derivados de imida- zol
AR240813A2 (es) N-fenilsulfonil-n'-pirimidinilureas, procedimiento para su preparacion, composiciones que las contienen e intermediarios para uso exclusivo en dicho procedimiento
ES465861A1 (es) Procedimiento de preparacion de 4-difenilmetilen-1-hidroxi- bencil-piperidinas.
ES468630A1 (es) Procedimiento para la obtencion de derivados de la isoquino-leina.
ES8603414A1 (es) Un procedimiento para preparar un derivado de 1, 4-dihidropiridina disustituido en posicion 2, 6
FR2373537A1 (fr) Derives de la piperazine utilisables comme medicaments
ES475077A1 (es) Un procedimiento para producir un tiolcarbamato.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19990405